Expert NetworkExpert InterviewCYTK

Slingshot members are talking to an expert! The topic is:

Discussing the label of Cytokinetics' Myqorzo (Aficamten) and how it may fare commercially vs Camzyos (Mavacamten)

Executed on:Jan 7, 2026 11:55 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Cedars-Sinai Medical Center
  • Associate Professor of Cardiology at both Cedars-Sinai and UCLA. Co-Director of the Hypertrophic Cardiomyopathy Clinic and Medical Director of the Hypertension Center at Cedars-Sinai 
  • Manages 250+ patients with oHCM
  • Principal investigator in multiple clinical trials investigating novel treatment options for hypertrophic cardiomyopathy and device-based therapies for hypertension. Published over 90 manuscripts focused on hypertrophic cardiomyopathy, hypertension, and valvular heart disease. 
 

Interview Goal

Discussing the recent approval of Myqorzo in oHCM

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.